
    
      Patients are inferred to 27 tertiary hospitals with the complaint of de novo complications
      after pelvic reconstructive surgeries using mesh, tape and native tissue between June 2018
      and June 2023. The subjects include patients who accept treatment not only at 27
      participating hospitals but also from other hospital. And the date of surgeries carried is
      not restricted in the study period.

      This is a study of real world. The researchers focus to investigate the incidence of
      complications in clinical practice.
    
  